DESIGN OF HEPATITIS E VIRUS GENOTYPE 1 RECOMBINANT ORF3 PROTEIN BY CODON OPTIMIZATION METHOD

Autor: G. I. Alatortseva, A. V. Sidorov, L. N. Nesterenko, L. N. Luhverchik, M. V. Zhukina, I. I. Amiantova, A. V. Milovanova, D. S. Vorobev, Yu. I. Ammur, M. I. Mikhailov, K. K. Kyuregyan, V. S. Kichatova, I. A. Potemkin, O. V. Isaeva, E. Yu. Malinnikova, A. A. Karlsen, V. M. Blinov, Z. Sh. Nurmatov, A. Z. Nurmatov, O. T. Kasymov, S. V. Zhavoronok, V. V. Zverev
Jazyk: ruština
Rok vydání: 2017
Předmět:
Zdroj: Журнал микробиологии, эпидемиологии и иммунобиологии, Vol 0, Iss 6, Pp 63-72 (2017)
Druh dokumentu: article
ISSN: 0372-9311
2686-7613
DOI: 10.36233/0372-9311-2017-6-63-72
Popis: Aim. The development of the hepatitis E virus (HEV) genotype 1 full-size ORF3 recombinant polypeptide. Materials and methods. Escherichia coli strains, plasmid vectors, serological and clinical samples, ELISA reagent kits, molecular biological, bioinformatic, biotechnological, biochemical and serological methods. Results. HEV genotype 1 RNA had been isolated from clinical samples collected in Kyrgyzstan. DNA copy of subgenomic virus RNA had been cloned and used for further development of E.coli strains producing full-size recombinant protein ORF3 fused to E.coli beta-galactosidase. Codons optimization method was used in aim to increase expression level of recombinant protein. Recombinant protein ORF3 had been isolated from the inclusion bodies of the E.coli biomass and purified by size exclusion chromatography. Antigenic specificity of recombinant polypeptide had been confirmed by enzyme-linked immunosorbent assay and Western blotting with the specific sera. Conclusion. HEVgenotype 1 ORF3 recombinant antigen had been designed, and it’s applicability in diagnostic tests had been experimentally confirmed.
Databáze: Directory of Open Access Journals